Juan Fortea on biomarkers of neurodegeneratio...

Metformin has received a lot of attention in the field of ageing, though clinical trials remain scarce. Dennis Villareal (Michael E. DeBakey VA Medical Center, Houston, USA) discusses the DEMFOS trial assessingl assessing whether adding metformin to an intensive lifestyle interve ...  Show more

The burden of musculoskeletal diseases is increasing. Dr Ara Nazarian tells us more about the issues surrounding this and how care can be improved in the USA.Read the full paper: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(25)00026-1/fulltext?dgcid=buzzsprout_ic ...  Show more

In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence. Firstly, last week they went to the first EBM Live conference for two years - and report back on what happ ...  Show more

Today's show rundown:

Short Telomeres in relation to COVID 19
Jeff talks more about telomeres and where you can find info
Mark introduces today's guest Dr. Dayan Goodenowe
Dr. Goodenowe talks a little about what he does and how he got started
Fun ...

Why are some of us more susceptible to dementia? What is a 'Super Ager'? And what might help us protect our brains in later life? In this focus episode of How We’re Wired join producer Dr Eva Higginbotham as she dives into the science of Super Agers, from the genes that increase ...  Show more

It's a podcast of pairs this time, for the latest issue of the journal. There's two hosts, two halves of the brain, two sides to a clinical debate, and two themes to the episode itself. Leading off is a discussion on peripheral neurology, taking a look at the editors' choice p ...